Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diltiazem for coronary microvascular dysfunction
NL-OMON49283Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Coronary Small Vessel Disease (CMD) and microvascular angina (MVA) comparing Diltiazem with Placebo (2 arms). Started Oct 2019; status: completed.
02
Drugs
diltiazem
03
Conditions
Coronary Small Vessel Disease (CMD)microvascular angina (MVA)
Beyond the preview
Go deeper on NL-OMON49283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49283.